Using the National Cancer Database, we identified women with T1-T2 N0 invasive breast cancers treated with lumpectomy during 2011. Adjuvant RT regimens were categorized as conventionally fractionated ...

Breast cancer is hard enough. Treatment should be quick and easy. That's the thinking of many physicians who have opted to offer MammoSite, a type of radiation that cuts treatment time from several ...

A biosignature tool helps women avoid unnecessary radiotherapy after undergoing lumpectomy for ductal carcinoma in situ (DCIS) ― and also identifies women who need more intense treatment. The ...

Breast cancer death rates have been declining since 1989, but the disease remains the second leading cause of cancer death in women. And incidence rates have increased slightly in recent years. For ...

Approval was supported by data from a randomized, intra-patient controlled trial, which included patients with confirmed invasive breast cancer, ductal carcinoma in situ, or both. The Food and Drug ...

Women diagnosed with early-stage breast cancer often can choose to have a lumpectomy, which removes only cancerous tissue and a thin margin of surrounding healthy cells instead of the entire breast.

NEW YORK (Reuters Health) - Radiation given for 22 days after surgery to remove a lump in the breast is just as effective as the standard 35-day course for women whose cancer has not spread to the ...

SAN ANTONIO -- A supplemental radiation boost delivered concurrently during hypofractionated whole-breast irradiation reduced treatment time, yet was just as effective in terms of recurrence, for ...

Women with the non-invasive form of breast cancer known as ductal carcinoma in situ (DCIS) are more likely to have a disease recurrence after treatment consisting of lumpectomy alone if: their lesion ...

Women with ductal carcinoma in situ—DCIS—who later develop invasive breast cancer in the same breast are at higher risk of dying from breast cancer than those who do not develop invasive disease, ...

A long-term follow up analysis of the NRG-RTOG 9804 randomized trial has shown that breast radiation following lumpectomy significantly reduces incidence of ipsilateral breast recurrence (IBR) for ...

An Oct. 19 Health article about Mammosite, a new radiation treatment for breast cancer, listed an incorrect phone number for Holy Cross Hospital, which offers the treatment. The correct number is ...